Sumary of Moderna releases new data on Covid breakthrough cases it says supports need for booster shots:
- Three Covid-19 related hospitalizations occurred in the group that got the shots early on, resulting in two deaths, according to the data.
- “There’s a large debate, we all know, about whether or not vaccine boosters are going to be necessary into the fall,” Moderna president Stephen Hoge said in a phone interview.
- Earlier Wednesday, FDA scientists declined to take a stance on whether to back booster shots of Pfizer’s Covid vaccine, saying U.S. regulators haven’t verified all the available evidence.
- It sets the stage for a tense meeting Friday as the Biden administration has said it wants to begin offering booster shots to the general public as early as next week, pending authorization from the FDA.
- The move is part of President Joe Biden’s broader plan to confront a higher number of Covid cases fueled by the fast-spreading delta variant.